01/06/06

Banking on bioprospecting in Costa Rica

Costa Rican orchid: researchers hope the nation's biodiversity will yield new drugs Copyright: IRD / Anthony

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>Banking on bioprospecting in Costa Rica</h1>
<h4></h4>
</div>
<br />
<br />

<div id="article-body">
<p>Researchers at Costa Rica’s flagship biodiversity institute are hoping that an ambitious new project will ease its financial worries.</p>
<p>The National Biodiversity Institute’s (INBio) five-year project aims to find chemicals in wild species that could form the basis of new drugs, reports Rex Dalton in Nature.</p>
<p>INBio’s previous efforts at ‘bioprospecting’ failed to yield major moneymaking products, and the institute hit financial problems when several grants ended in 2005 (see <a target="_self" href="/News/index.cfm?fuseaction=readnews&itemid=2400&language=1" rel="noopener noreferrer">Funding crisis hits Costa Rican biodiversity institute</a>).</p>
<p>This time around INBio is looking for compounds that can be easily isolated and duplicated from sources such as fungi, leaves or bacteria, instead of focusing on insects as it did previously.</p>
<p>The findings will eventually be entered into a free access database for researchers around the world to investigate. Profits from successful findings will be ploughed back into INBio in the form of licence fees.</p>
<p><a onclick="pageTracker._trackPageview('/tracking/external/'+this.href);" target="_blank" href="http://www.nature.com/nature/journal/v441/n7093/full/441567a.html" rel="noopener noreferrer">Link to full article in Nature</a></p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/global/features/banking-on-bioprospecting-in-costa-rica/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/global/features/banking-on-bioprospecting-in-costa-rica/",null,true])
</script>
</div>

Researchers at Costa Rica’s flagship biodiversity institute are hoping that an ambitious new project will ease its financial worries.

The National Biodiversity Institute’s (INBio) five-year project aims to find chemicals in wild species that could form the basis of new drugs, reports Rex Dalton in Nature.

INBio’s previous efforts at ‘bioprospecting’ failed to yield major moneymaking products, and the institute hit financial problems when several grants ended in 2005 (see Funding crisis hits Costa Rican biodiversity institute).

This time around INBio is looking for compounds that can be easily isolated and duplicated from sources such as fungi, leaves or bacteria, instead of focusing on insects as it did previously.

The findings will eventually be entered into a free access database for researchers around the world to investigate. Profits from successful findings will be ploughed back into INBio in the form of licence fees.

Link to full article in Nature